Rivernorth Capital Management’s Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( CHAQ.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-179,886
Closed -$115K 717
2021
Q2
$115K Hold
179,886
0.01% 389
2021
Q1
$169K Hold
179,886
0.01% 338
2020
Q4
$178K Sell
179,886
-42,614
-19% -$32.3K 0.01% 271
2020
Q3
$160K Buy
+222,500
New +$156K 0.01% 247

Rivernorth Capital Management's CHAQ.WS Position: Q3 2021 in Review

Rivernorth Capital Management sold out of Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( (CHAQ.WS) in Q3 2021, closing a stake of 179,886 shares — an estimated $115K sold.

Rivernorth Capital Management first reported a position in CHAQ.WS in Q3 2020 and held it in 4 quarters. The position peaked at $178K in Q4 2020. 0 funds tracked by Wall St. Rank hold CHAQ.WS as of Q3 2021.

  • Rivernorth Capital Management reported no remaining Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position as of Q3 2021 after selling out during the quarter.
  • Rivernorth Capital Management sold 179,886 Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( shares in Q3 2021, an estimated $115K.
  • Rivernorth Capital Management first reported a position in Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( in Q3 2020 and held it in 4 quarters.
  • Rivernorth Capital Management's Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position peaked at $178K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( as of Q3 2021.

Based on Rivernorth Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.